Two orthogonal gold-nanoparticle-based DNA nanosensors that enable simultaneous imaging of sodium/hydrogen exchanger 1 (NHE1) mRNA and Na+ dynamics in hepatocellular carcinoma cells are reported, providing a molecular tool for decoding ion-based signaling networks in cancer biology.
Abstract
Cellular signaling networks are orchestrated by complex interactions between gene expression and ion flux, yet tools for simultaneously visualizing these events in living cells remain limited. Herein, we report two orthogonal gold-nanoparticle-based DNA nanosensors that enable simultaneous imaging of sodium/hydrogen exchanger 1 (NHE1) mRNA and Na+ dynamics in hepatocellular carcinoma cells. The sensing mechanism relies on proximity-dependent fluorescence quenching. For mRNA detection, Cy3-labeled reporter strands hybridize to DNA-functionalized gold nanoparticles (AuNPs), holding the fluorophore close to the quenching surface. Target binding triggers strand displacement, releasing Cy3, and restoring emission. For Na+ detection, a Cy5-labeled substrate strand hybridizes with a Na+-specific DNAzyme anchored on AuNPs. Na+ activates the DNAzyme, cleaving the substrate at a defined site and liberating the Cy5 fluorophore. This dual-sensor system enables the quantitative monitoring of both analytes in living cells. Using this platform, we directly visualize that NHE1 mRNA downregulation suppresses intracellular Na+ accumulation, establishing a regulatory link between gene expression and ion homeostasis. Notably, mRNA-targeted hybridization inhibits cancer-cell migration in a dose-dependent manner, revealing a potential therapeutic mechanism. This approach provides a molecular tool for decoding ion-based signaling networks in cancer biology.
Both in vitro experiments and in situ lysosomal K+ imaging along with external pharmacological stimuli demonstrated the excellent performance of the proposed K+ nanosensor, which expanded the application of DNA-based probes in subcellular imaging field.
Guangming Li, Ying An, Jia-Hui Sun et al.· Biosensors & bioelectronics· 0 citations
Both in vitro and in vivo studies validate the feasibility of this robust and versatile nanoplatform that merges targeted delivery and endogenous activation for precise cancer imaging and therapy, with the potential for adaptation to diverse sensing and therapeutic payloads through modular reprogramming.
Yunhong Han, Weijie Tong, Fei Ma et al.· Small· 1 citation
It is demonstrated that mammalian cells maintain Mg2+ homeostasis even under conditions of elevated extracellular Mg2+, revealing the robustness of intracellular regulatory mechanisms governing Mg2+ balance.
Xin Xie, Bibi Zhang, Ming-Yan Liu et al.· ACS Sensors· 0 citations
A DNA nanodevice that anchors to cell membranes and releases chemotherapy only when three specific cancer markers are detected simultaneously is developed, establishing a versatile platform for logic‑controlled, multimarker‑guided cancer theranostics.
Meiqin Zhang, Ying-Sheng Cheng, Nan Chen et al.· Nature Communications· 0 citations
An APE1-powered AND-gated DNA walker with autocatalytic amplification (AWA) for the imaging of dual intracellular miRNAs provides a powerful tool for intracellular miRNA analysis and shows significant potential for early cancer diagnosis.
Liu-Ting Mo, Dan-Ting He, Yi Zeng et al.· Analytical Chemistry· 0 citations
A light-regulated iontronic biosensor for sensitive detection of exosomal m5C-modified microRNA-21 (m5C-miR-21) by regulating the charge-steric trade-off during hydrogel formation by regulating the charge-steric trade-off during hydrogel formation is reported.
Baojing Jiang, Tianyi Lu, Yan-Lei Li et al.· Analytical Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.